HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

France Restricts NRT Sales As Nicotine Patches Trialled As COVID Treatment

Executive Summary

Fearing a rush on nicotine patches by COVID-19 sufferers, France is restricting OTC sales of NRT products. 

You may also be interested in...



Studies To Investigate If Betadine Mouthwash Can Prevent COVID-19 Infection

Clincal studies planned to test if povidone-iodine, marketed widely as consumer health products under the brand name Betadine, can prevent infection with the novel coronavirus.

France Warns Supplements Can Interfere With Immune Response To COVID-19

Dietary supplements containing certain plants can inhibit the immune response to COVID-19 and should not be taken by those showing symptoms of the virus, according to French regulator ANSES.

France Limits Sale Of OTC Analgesics In Response To Covid-19

France limits OTC sales of paracetamol to one pack per person with no Covid-19 symptoms and two packs for those with pain and/or fever. Online sales of medicines containing paracetamol, ibuprofen and/or aspirin are also now suspended.

Topics

UsernamePublicRestriction

Register

RS149968

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel